Navigation Links
Hand Extension Device

ProductsHand Extension Device
Company Stryker Leibinger Micro Implants
Item Hand Extension Device
Features 
  • Arthroscopy of the wrist
  • Ability to undertake immediate surgical intervention without changing the operative set-up
  • Surgery of the shaft of the thumb
  • Trapezo-metacarpal arthrosis
  • Fracture or pseudoarthrosis of the scaphoid
  • Fracture of the base of the first metacarpal
  • Description For diagnostic and operative treatment of hand and wrist bones. The use of this distraction device allows fracture reduction or widening of the space between bones.
    Info Stryker Leibinger Micro Implants
    Customer Service: (269) 324-5346

    Related medicine products :

    1. QWIKCABLE Autoclavable Extension Cable
    2. Accessories Extension Cables Disposable and Reusable
    3. Amsco® 3080/3085 SP™ Bariatric Foot Extension
    4. Amsco® 3080/3085 SP™ Bariatric Orthopedic Extension
    5. Amsco® 3080/3085 SP™ Bariatric Table Extensions
    6. Dale® Tracheostomy Tube Holder - Extension Piece
    7. VixOne Infant Extension Set
    8. EGG 4 Channel Extension
    9. Motion Sensor Extension Cable
    10. Frechet Extender® Skin Extension Device
    11. Scoliosis Devices
    Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Using Your Immune System to Fight Cancer 58734 1U S Census Bureau Daily Feature for Oct 2 58730 1Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 1Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 2